Are women with PCOS more at risk for endometrial cancer? What approach for such patients?

Main Article Content

Vladislava Valerievna Khalenko
Rosa Anna Guiglia
Marta Alioto


Policystyc ovarian syndrome (PCOS), Endometrial cancer (EC), Endometrial hyperplasia, Confounding factors


Download data is not yet available.
Abstract 115 | PDF Downloads 81


1.Tanos P, Dimitriou S, Gullo G, Tanos V. Biomolecular and Genetic Prognostic Factors That Can Facilitate Fertility-Sparing Treatment (FST) Decision Making in Early Stage Endometrial Cancer (ES-EC): A Systematic Review. Int J Mol Sci. 2022 Feb 28;23(5):2653. doi: 10.3390/ijms23052653.
2.Mutlu L, Manavella DD, Gullo G, McNamara B, Santin AD, Patrizio P. Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive Outcomes. Cancers (Basel). 2022 Oct 22;14(21):5187. 
3.Gullo G, Carlomagno G, Unfer V, D'Anna R. Myo-inositol: from induction of ovulation to menopausal disorder management. Minerva Ginecol. 2015 Oct;67(5):485-486.
4.Bezerra Espinola MS, Laganà AS, Bilotta G, Gullo G, Aragona C, Unfer V. D-chiro-inositol Induces Ovulation in Non-Polycystic Ovary Syndrome (PCOS), Non-Insulin-Resistant Young Women, Likely by Modulating Aromatase Expression: A Report of 2 Cases. Am J Case Rep. 2021 Oct 7;22:e932722. doi: 10.12659/AJCR.932722.
5.Prapas Y, Petousis S, Panagiotidis Y, et al. Injection of embryo culture supernatant to the endometrial cavity does not affect outcomes in IVF/ICSI or oocyte donation cycles: a randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2012 Jun;162(2):169-173. doi: 10.1016/j.ejogrb.2012.03.003.
6.Cavaliere AF, Perelli F, Zaami S, et al. Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification. Int J Mol Sci. 2021 Nov 12;22(22):12248. doi: 10.3390/ijms222212248.